Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Voice ; 31(1): 127.e1-127.e6, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26856478

RESUMEN

OBJECTIVES: The clinical application of allogenic and/or xenogenic cartilage for vocal fold augmentation requires to remove the antigenic cellular component. The objective of this study was to assess the effect of cartilage decellularization and determine the change in immunogenicity after detergent treatment in human nasal septal cartilage flakes made by the freezing and grinding method. METHODS: Human nasal septal cartilages were obtained from surgical cases. The harvested cartilages were treated by the freezing and grinding technique. The obtained cartilage flakes were treated with 1% Triton X-100 or 2% sodium dodecyl sulfate (SDS) for decellularization of the cartilage flakes. Hematoxylin and eosin stain (H&E stain), surface electric microscopy, immunohistochemical stain for major histocompatibility complex I and II, and ELISA for DNA contents were performed to assess the effect of cartilage decellularization after detergent treatment. RESULTS: A total of 10 nasal septal cartilages were obtained from surgical cases. After detergent treatment, the average size of the cartilage flakes was significantly decreased. With H&E staining, the cell nuclei of decellularized cartilage flakes were not observed. The expression of major histocompatibility complex (MHC)-I and II antigens was not identified in the decellularized cartilage flakes after treatment with detergent. DNA content was removed almost entirely from the decellularized cartilage flakes. CONCLUSION: Treatment with 2% SDS or 1% Triton X-100 for 1 hour appears to be a promising method for decellularization of human nasal septal cartilage for vocal fold augmentation.


Asunto(s)
Detergentes/farmacología , Cartílagos Nasales/efectos de los fármacos , Tabique Nasal/efectos de los fármacos , Octoxinol/farmacología , Dodecil Sulfato de Sodio/farmacología , Recolección de Tejidos y Órganos/métodos , Pliegues Vocales/cirugía , ADN/análisis , Congelación , Antígenos de Histocompatibilidad Clase I/análisis , Antígenos de Histocompatibilidad Clase II/análisis , Humanos , Cartílagos Nasales/inmunología , Cartílagos Nasales/trasplante , Cartílagos Nasales/ultraestructura , Tabique Nasal/inmunología , Tabique Nasal/trasplante , Tabique Nasal/ultraestructura
2.
J Investig Allergol Clin Immunol ; 18(6): 469-72, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19123440

RESUMEN

Severe congenital neutropenia (SCN) is a primary immunodeficiency disease characterized by early onset of severe bacterial infection and persistent severe neutropenia. We describe an SCN patient with a history of recurrent infections. The clinical course was complicated by necrosis of the nasal cartilage due to mucormycosis. Molecular studies revealed a homozygous germline HAX1 mutation. Fungal infections may lead to serious complications in immunodeficient patients. Recurrent and severe infections should alert physicians to possible immunodeficiency disease. Early diagnosis and appropriate treatment are the most important keys to preventing irreversible organ damage.


Asunto(s)
Mucormicosis/patología , Cartílagos Nasales/patología , Neutropenia/patología , Proteínas/genética , Proteínas Adaptadoras Transductoras de Señales , Niño , Femenino , Humanos , Mucormicosis/complicaciones , Mucormicosis/genética , Mucormicosis/inmunología , Cartílagos Nasales/inmunología , Cartílagos Nasales/microbiología , Necrosis , Neutropenia/genética , Neutropenia/inmunología , Neutropenia/microbiología , Linaje
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...